ACADEMIC/CHARITABLE/ VOLUNTARY BODY INTERESTS. None None None

Transcription

1 Medications in recovery: re-orientating drug dependence treatment Appendix B Expert group declarations of interest Declarations only apply to full members of the expert group, not to corresponding members or observers MICHAEL ASHTON DR ALISON JANE BATTERSBY DR JAMES BELL KAREN BIGGS DR OWEN BOWDEN-JONES JAYNE BRIDGE Through Findings, works in partnership with DrugScope and the National Addiction Centre Psychiatry input into Broadreach and Trevi (via contract with employer) Employed by Plymouth community healthcare Addictions Division, South and Maudsley NHS Chief Executive, Phoenix Futures, substance misuse recovery organisation Central & North West NHS Foundation Trust Lead for nursing and quality, Mersey Care NHS Trust QPCN peer educator training unrestricted educational grant from EATA accreditation panel Complimentary ticket to CCSAD from C4 recovery solutions Attended conferences sponsored by Schering Plough in Glasgow, Hamburg, Italy and Paid expenses to speak at conferences supported by Scottish Drugs Forum and Medineo Attends quarterly regional addiction psychiatry meetings sponsored by Britannia Spoke to GPs and hepatologists re NICE guidance, Wyeth sponsored, payments to local charity Reviews articles and books for several journals on an ad hoc basis Attended global addictions conference in Lisbon sponsored by Previously funded by, Titan Pharmaceuticals, Schering-Plough corporation, Biomed P/L, to undertake clinical research, to attend conferences and present results, and to speak at Medical CPD meetings Board member, The Alliance, Board Member, European Federation of Therapeutic Communities Chaired a webcast for Servier re agomelatine, payment to Broadreach Trustee, Twelves Company Exec committee member and Academic Secretary, Royal College of Psychiatrists Represent RCPsych on Recovery Group UK On residential rehab expert group chaired by David Burrowes Member, Recovery Academy Attended advisory boards for Schering Plough, expenses paid but fee to local charity Member, Clinical Partners, a private referral agency and will be registering with insurance companies for private opinions 1

2 ANNE CHARLESWORTH ALEXANDRE GEORGES COPELLO DR EDWARD DAY SELINA DOUGLAS Lead commissioner for drugs and alcohol services, NHS Rotherham Consultant clinical psychologist, NHS, on occasions involved in the competitive tendering process for treatment contracts, although this is limited as not involved in general management of the services I work for an NHS, and so I am involved in the competitive tendering process for treatment contracts, although I do not hold a management position Director of Substance Misuse, Turning Point Partner is assistant director for substance misuse, Rotherham, Doncaster and South Humber NHSFT VIVIENNE EVANS Chief Executive, Adfam Adfam has received funding from Reckitt Benckiser to undertake a project to identify and tackle stigma associated with substance misuse for families EILISH GILVARRY JASON GOUGH Honorary Professor of Addiction Psychiatry, University of Newcastle upon Tyne Consultant psychiatrist in addictions, Northumberland, Tyne and Wear NHS Clinical Director of specialities including addictions Patient Opinion substance misuse lead Consultant on service user engagement to Group plc Service user representative NTA Professor at a UK University. Principal Investigator on research projects that receive funding from the NIHR (Social Network interventions for patients on OST, brief intervention for people with severe mental health problems). Regularly applies for research funding. Regular reviewer of grant applications and academic paper submissions for various journals Researcher working for a UK University. Principal Investigator on research projects that have received funding from the NIHR (Social Network interventions for patients receiving opioid substitution treatment, naltrexone for relapse prevention after opioid detoxification) Received payment from the NTA for developing treatment manuals as part of the Routes to Recovery series. Member, NICE substance use disorders quality standards committee President, Society for the Study of Addictions Trustee, Medical Council on Alcoholism Executive Member, Faculty of Addictions, Royal College of Psychiatrists Chair, Yorkshire & Humber service user forum Member, National Recovery Advocates Member, Yorkshire & Humber Recovery Forum Vice Chair, Substance Misuse Skills Consortium 2

3 KATE HALL Assistant Director, Greater Manchester West Mental Health Foundation NHS Trust GMW have partnership arrangements with Lifeline in delivering services in Central Lancashire DR LINDA HARRIS Chief Executive and Director, Spectrum Community Health Community Interest Company, a not for profit employee-owned healthcare organisation providing substance misuse, offender health and contraception and sexual healthcare services Clinical Director, RCGP Substance Misuse and Associated Health SMAH provides a portfolio of education and training for GPs and other practitioners involved in treating drug and alcohol addiction and supporting holistic recovery DR MICHAEL KELLEHER Consultant psychiatrist, South and Maudsley NHS Honorary contract at the Institute of Psychiatry (KCL) Received unrestricted fee to speak at two European conferences on addiction by Schering Plough and Reckitt Benckiser in the past two years Secured major new research grant ( 1m over three years from July 2012) to develop a new adaptive maintenance clinic. Funding from Reckitt- Benckiser to the charity Action on Addiction in form of an unrestricted educational grant DR BRIAN ALISTAIR KIDD Consultant psychiatrist, NHS Tayside Lead clinician for a regional addictions service. This involves chairing the NHS service Senior management team as well as sitting on formal committees within the NHS Board accountability structure including the Angus Community Health Partnership Committee and Tayside Mental Health Joint clinical Board. I represent the NHS Board on local strategic and commissioning groups (Dundee City Alcohol & Drug Partnership and its Commissioning Group) Independent Chair, Scottish Drug Strategy Delivery Commission an independent body which advises the Scottish Government on its progress regarding its strategic objectives. This position attracts no additional remuneration Clinical academic, University of Dundee. I carry out research in the field of addictions. Since working in Tayside (2003) no research or other interests have been funded by the pharmaceutical industry or any commercial business 3

4 TIM LEIGHTON Employed from 1985 to present by Action on Addiction, which among other activities provides abstinence-based treatment in residential and day programmes, and services to family members PETER MCDERMOTT NEIL MCKEGANEY LUKE MITCHESON DR GORDON RIDDING MORSE MORAG MURRAY NOREEN OLIVER MBE DR STEVE PILLING Project coordinator, The Alliance Director, Centre for Drug Misuse Research, Glasgow Psychologist, South and Maudsley NHS (SLaM) Seconded to National Treatment Agency one day a week, for which NTA pay SLaM Clinical Lead, Somerset Community Specialist Drug and Alcohol Service (Turning Point) Internal Associate Clinical Director, Turning Point Substance Misuse Directorate (formerly Principal in General Practice and Medical Consultant to Action on Addiction) Service Director, Sussex Partnership NHS Chief Executive Officer, BAC O Connor University College Camden & Islington NHS Received research funding from Reckitt Benckiser Past consultancy to Schering Plough and on issues of drug treatment and development of patient resources, I have acted and been paid independently for my time Clinical Director Drug Treatment Ltd Honorary Researcher at the National Addictions Centre Non-executive director, Lifeline Project Director, Substance Misuse and Crime Research Involved in two research projects for which SLaM received financial support from NTA: Contingency management to support abstinence from cocaine Psychosocial programme to motivate people on OST to achieve recoveryrelated goals Involved in research programme looking at developing an optimal psychosocial / pharmacological treatment programme to support recovery for which SLaM has received money via Action on Addiction from Regional Drug Training Lead, Royal College of General Practitioners Executive Member, RCGP Substance Misuse and Allied Health Adviser, National Association for Children of Alcoholics Member, Amicus Supporter of Release BAC O Connor Centres: Burton Addiction Centre Burton upon Trent O Connor Centre Newcastle under Lyme The O Connor Gateway Charitable Trust University College Chair, Recovery Group UK Co-chair, The Recovery Partnership Co-chair, The Rehabilitation Expert Working Group Develops clinical guidelines for NICE 4

5 JAMES ROY ROBERTSON JOHN STRANG IAN WARDLE General Medical Practitioner (NHS full time) Leads the Addictions academic activity of the Institute of Psychiatry, Kings College, which includes conduct of diverse research studies and provision of educational activity in the Addictions. Also in a leadership position for the Addictions clinical activity of the South & Maudsley (SLaM) NHS Foundation Trust, which provides treatments in the drug, alcohol and smoking cessation fields CEO, Lifeline, a third sector provider that regularly bids for drug treatment contracts Occasional advisory committee work with various pharmaceutical companies. Limited to 2-3 days per year and only remuneration is travel expenses and small honorarium Received project grant support and/ or honoraria and/or consultancy payments from Department of Health, NTA (National Treatment Agency), Home Office, and NICE (National Institute for Health and Clinical Excellence). Worked with WHO (World Health Organisation) and with UNODC (United Nations Office for Drug Control) and other international government agencies. Has also received research grant support and/or payment in the form of honoraria, consultancy payments and/or travelling and/ or accommodation and/ or conference expenses from pharmaceutical companies who produce, or have been considering producing, new medicines for use in the addiction treatment field, including (past 3 years) Genus (Britannia), Viropharma (Auralis), Martindale (Catalent), Reckitt- Benckiser, Schering- Plough, Lundbeck, UCB, Napp (MundiPharma), Fidelity International and also discussions with Lightlake and Lanacher Grant holder in Scottish Government supported research activities Worked closely with the charity Action on Addiction, and also with the J Paul Getty Charitable Trust (JPGT) and the Pilgrim Trust, and has received grant support from them. Previous close links with charitable funded providers, including Lifeline (Manchester), Phoenix House, and currently with KCA UK (Kent Council on Addictions), and Clouds (Action on Addiction) Chairman, Scottish committee of the National Forum on Drug Related Deaths Member, Scottish Drugs Delivery Commission Works with various drug policy organisations and advisory bodies including the UK Drug Policy Commission (UKDPC), the Society for the Study of Addiction (SSA), and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Coordinates research and evidence work group of the Substance Misuse Skills Consortium 5